pared aspects of narrow-gauge surgery to traditional sutured 20g surgery [9] [10] [11] . Studies have also found a reduction in peripheral retinal break formation near the sclerostomy sites with the cannulated sclerostomies used in narrow-gauge systems [12, 13] .
Surprisingly little investigation has been carried out into whether there are any differences in outcomes between 23g and 25g surgeries. Although commonly grouped together, there are multiple differences between 23g and 25g systems including sclerostomy size, instrument stiffness and utility, as well as fluidic capabilities and tissue attraction [3, 14] . A comparison of small-gauge systems is now of particular relevance given that 27-gauge (27g) systems are becoming available [15] .
This study focuses on a series of patients who were undergoing 23g and 25g vitrectomy for proliferative diabetic retinopathy (referred to as diabetic vitrectomy) by one surgeon over a 3-year period. In particular, we analysed intraoperative and postoperative events to see if there were any differences in outcome between the two gauge sizes.
Methods
This is a retrospective, comparative, and consecutive record review conducted in the Sunderland Eye Infirmary. A consecutive series of patients who had undergone primary pars plana vitrectomy for the complications of proliferative diabetic retinopathy by one surgeon at Sunderland Eye Infirmary from January 2010 to March 2013 was prospectively identified, and data using predetermined definitions were entered into the surgeon's own electronic database. For analysis, the cases were divided into two groups: (1) a first group from January 2010 to September 2011 where only 23g vitrectomy surgery was carried out and (2) a second group from October 2011 to March 2013 where only 25g vitrectomy surgery was carried out.
A variety of pre-, intra-and postoperative characteristics of the patients were recorded, including age, sex, type and duration of diabetes. The amount of preoperative panretinal photocoagulation administered was graded as equal to, or more than, ETDRS full scatter, less than standard ETDRS full scatter or no preoperative laser surgery [16] . The extent and position of vitreoretinal adhesion present was recorded by Yorston et al. [17] as none, disc attachment only, posterior pole attachment only or 1-4 quadrants of anterior vitreoretinal attachment. Patients were followed up at 1 day, 2 weeks, and 6 months postoperatively as a minimum and as needed according to the clinical circumstances.
All surgeries were carried out using the Alcon Constellation 23g and 25g systems (Alcon, Forth Worth, Tex., USA). A wideangle non-contact indirect viewing system, with an in-built image inverter, was used in all cases. The Edge plus One Step entry system was used in all cases, and the technique was common with both gauges. After conjunctival displacement, acutely oblique entry into the sclera was made with the trocar and continued until the sclerostomy cannula abutted the sclera. The trocar was then moved 30° to the globe and final entry was made.
Core vitrectomy was carried out using a cut rate of 5,000 cuts/ min (CPM) with proportional vacuum settings and a maximum vacuum of 350 mm Hg for 23g and 550 mm Hg for 25g. Intraocular pressure (IOP) was set at 26 mm Hg, and the IOP compensation system was activated for both groups with intermittent raised pressure for haemostasis as required. After core vitrectomy, delamination and removal of all posterior hyaloid face and fibrovascular membranes was carried out. This was done primarily with the vitreous cutter alone, and intravitreal scissors were used only if necessary. When performing cutter delamination, a 3D mode was applied with a biased closed duty cycle, and a cut rate of 3,000 CPM declining to 1,500 CPM as previously described [18] . In no cases was a sclerotomy opened up for 20g instruments. Careful inspection to detect the presence of vitreoschisis was carried out, and staining of residual vitreous gel using diluted triamcinolone was used routinely in all cases. Any vitreoschisis detected was peeled using the vitreous cutter and forceps as necessary. Peripheral vitreous was removed, especially around the inner sclerotomy wounds, with deep scleral indentation.
Endolaser retinal laser photocoagulation was carried out to complete any deficiencies in previous laser surgery and was also performed up to the ora serrata in all eyes. An internal search using endoviewing and indentation with a non-contact wide-field viewing system was applied. Retinal breaks were treated with argon laser retinopexy or cryotherapy. The breaks were classified as being either posterior and usually related to dissection or surgical traction or peripheral related to vitreous separation; these were further divided into entry site-related breaks occurring with one clock hour on either side of the sclerostomies or other vitreous separation-related breaks. Silicone oil, sulphur hexafluoride (SF 6 ) gas or air were used as postoperative tamponade where needed. Preoperative anti-VEGF therapy was used in selected patients relating to the activity and extent of the neovascularization. Combined phacovitrectomy was carried out in cases with visually significant cataract obscuring the operative view.
At the end of surgery, and after sclerostomy guard removal, sclerostomy closure was checked by inflating the eye to a pressure of 30 mm Hg using a 30g needle inserted through the pars plana connected to an airline. If any sclerostomy leak was present, an 8-0 absorbable suture was used to secure the wound.
Postoperative vitreous cavity clarity was recorded on a 4-point scale from 0 to 3, with 0 being completely clear and 3 being a dense haemorrhage with no red reflex visible as used previously [19] . Any postoperative vitreous cavity haemorrhage (POVCH) was categorized as early (present on the first postoperative day or occurring within the first postoperative 3-week period) or late (occurring >3 weeks postoperatively).
Eyes with previous vitrectomy surgery were excluded from the study. In 1 patient in the 23g group and in 2 patients in the 25g group silicone oil was used, and these were excluded from further analysis but are presented in table 5.
The groups were compared using Minitab 16 (Minitab Ltd., Coventry, UK) for statistical analysis. Case characteristics were calculated using descriptive statistics, including mean and SD. Categorical variables were compared using Fisher's exact test and Pearson's χ 2 test as appropriate. Means were compared using Student's t test for unequal variance; p values of <0.05 were considered statistically significant. Snellen chart measurements were convertGuthrie /Magill /Steel Ophthalmologica 2015;233:104-111 DOI: 10.1159/000369258 106 ed to logarithmic minimum angle of resolution, LogMAR, for statistical analysis. Acuity values were assigned to counting fingers and hand motion as recommended by Holladay [20] . All national and regional ethic guidelines were adhered to throughout the study. Our prospective database was appropriately registered with the local hospital database officers.
Results
During the study period, there were 80 eyes of 78 patients that had 23g vitrectomy and 80 eyes of 79 patents that had 25g vitrectomy for complications related to proliferative diabetic retinopathy. Eyes with previous vitrectomy surgery were excluded (n = 0) as were eyes which required silicone oil (n = 3).
The groups were well matched with a mean age of approximately 52 years. In particular, the duration of diabetes, HbA1c level and the preoperative use of blood-thinning agents did not differ significantly. The groups were also similar in terms of their indications for surgery and complexity in taking into account the extent of vitreoretinal attachment present ( table 1 ) .
A 6-month follow-up was achieved in 96 and 97% of the 23g and 25g groups, respectively. Both groups had significantly improved vision at 6 months (p ≥ 0.0001), but there were no significant differences between visual acuities at any of the time points recorded ( table 2 ). Sim- ilarly, the frequency of cataract surgery following vitrectomy was equivalent. Eighteen (23%) eyes in the 23g group required at least one sclerostomy suture compared to only 6 (8%) eyes in the 25g group (p = 0.014). There was no significant difference between mean day 1 and day 14 IOPs, but there were significantly more patients with a day 1 IOP of <6 mm Hg in the 23g group (p = 0.034) ( table 2 ). Scissors were necessary in 6 patients in the 23g group and in 3 patients in the 25g group (p = 0.49). There was no significant difference in the type and frequency of retinal breaks between the two groups ( table 3 ). There was 1 case of postoperative retinal detachment in the 23g group and none in the 25g group ( table 3 ) . No significant differences were found in the day 1 and day 14 vitreous cavity clarity secondary to haemorrhage between the groups or in the rate of occurrence of early and late POVCH ( table 2 ). Table 4 details adverse outcomes which were encountered during the study, and table 5 discusses the excluded eyes which required silicon oil.
Discussion
This study sought to compare the surgical outcomes of 25g and 23g vitrectomy in patients with proliferative diabetic retinopathy. We chose diabetic vitrectomy because of the well-known side effect and complication profile. The 160 surgeries analysed were carried out over a 3-year period by a single surgeon. Our 23g and 25g cohorts were both well matched, with none of the baseline variables recorded differing significantly between the groups. Importantly, the surgical complexity was well matched with no significant difference in the extent of vitreoretinal adhesion between the two groups.
Visual improvement and rates of surgical complications were broadly similar between the groups. The only outcomes which reached significance were the increased frequency of sclerostomy suture and postoperative hypotony in the 23g group. The two groups used the same entry system design and oblique entry technique, and the difference must relate to the size of the sclerostomy. At the conclusion of surgery, all eyes, even if not requiring tamponade, had a partial fluid/air exchange; then the eyes were inflated to a pressure of 30 mm Hg with a 30g needle. More 23g sclerostomies required suturing based on this protocol. Despite this, there was still a higher hypotony rate in the 23g group on the first day. Transient hypotony (IOP <6 mm Hg) 1 day postoperatively occurred in 10% 109 of 23g and in 2% of 25g surgeries in our cohort, which was a significant difference (p = 0.034). Transient hypotony of 23g has been noted in several other studies. Park et al. [21] found 0% (66/101) of their 20g and 22% (45/101) of their 23g group to be under <8 mm Hg at day 1 postoperatively. Both Akçay et al. [22] and Lott et al. [23] similarly found high rates of transient hypotony in their 23g groups; 9.8% (34/350) and 10% (10/100) of the eyes treated with 23g had an IOP of <6 mm Hg 1 day postoperatively. It is well recognized that 20g surgery carries less risk of day 1 hypotony. Framme et al. [24] studied IOP after 20g surgery and found that transient low IOP was infrequent in 1.2% (10/851) of eyes. IOP after 25g surgery has been less frequently investigated. Gupta et al.
[25] found a rate similar to that in our study of 5.7% (4/75).
A feared consequence of day 1 hypotony is intraocular haemorrhage with larger sclerostomies. Therefore, we may have expected to find an increased incidence of day 1 vitreous cavity haemorrhage in the 23g group on account of the higher rate of day 1 hypotony. This, however, was not the case; both groups had similar rates of POVCH both early and late. This could be due to the sample size being too small to detect any difference.
Previous studies into small-gauge surgery for diabetic vitrectomy have compared rates of POVCH between 20g and 23g systems, or evaluated a specific gauge rate independently. POVCH has been reported as being more frequent with larger-gauge instruments. Yang et al. [26] recorded a 1-month rebleed rate of 18% in 20g and 7% in 25g surgeries. Farouk et al. [27] reported a series of 200 with a rebleed rate of 11% in 25g surgeries. Our study did not find there to be any marked difference in rebleed rates between the 23g and 25g groups at any time period. The total number of patients requiring further surgery for POVCH was 9% in the 23g group and 6% in the 25g group (p = 0.77). These results are similar to the 10.4% reoperation rate found by Schoenberger et al. [28] in series of 174 25g operations.
A reported benefit of transconjunctival small-gauge surgery over 20g is faster visual recovery [12, 13] . This study did not find that this trend continues when comparing 23g to 25g. We observed no significant difference in the speed of visual recovery between the groups using the 14-day and 6-month time points as a guide.
The settings used for core vitrectomy between the two gauges actually result in very similar achievable flow rates in the vitreous, and we did not note any clinically relevant difference in the duration of surgery between the groups although we did not record this systematically. However, as the gauge size reduces, the sphere of influence of fluid flow around the port also reduces [14] . The effect of the vitrectomy probe-induced fluid flow is therefore more localized in smaller gauges meaning that it exerts less traction on distant tissue and, with the smaller port size, is more exact when carrying out cutter dissection. This may mean that scissor use will less often be required and that the iatrogenic break rate may be reduced using smaller gauge rates. However, we did not find this difference comparing the 23g and 25g groups. Several papers have reported that significantly fewer peripheral retinal breaks are caused by cannulated 23g systems compared to the 20g [12, 13, 29] . Our entry site break rate was very low in both groups at 1 eye in each group as may have been expected since the cannulated sclerostomy system is identical in length in each gauge at 6 mm. The use of scissors was marginally greater in the 23g group, and there was a non-significant higher number of posterior iatrogenic breaks and other posterior vitreous detachment-related breaks, and it may be that larger studies would show a difference. It will be of great interest to contrast our reported rates of peripheral retinal breaks and other complications with the upcoming 27g system to see if any significant advantage can be accrued by having a yet smaller gauge system. There was only 1 case of postoperative detachment in the study, and it underlies the importance of break detection and treatment for detachment prevention.
There has been a long running debate over a possibly higher rate of endophthalmitis in transconjunctival narrow-gauge surgery compared to sutured 20g surgery. Earlier research found that rates were increased in smaller-gauge surgery [30] . However, more recent and larger studies have found no significant difference in the rate of endophthalmitis with smaller-gauge surgery [31, 32] . It is likely that these differing conclusions reflect the evolution of small-gauge surgery: improving surgical technique and advancing technology have perhaps resulted in a decreasing incidence of endophthalmitis. We had no cases of endophthalmitis in either group, but the incidence of this complication is very low and substantially larger studies would be needed to investigate this further.
This study has several strengths. It is the largest direct comparison of outcomes of 23g and 25g surgeries for diabetic vitrectomy, with all operations being carried out by a single surgeon. Every new surgical system has a learning curve, but the surgeon had been using both 23g and 25g surgery for several years before the data was gathered. Both groups in the study were well matched medically and demographically. Lastly, its findings are in keeping with previous works which looked at 25g and 23g systems in isolation.
However, the study also has several weaknesses. Firstly, as with many vitreoretinal studies, there is insufficient power to facilitate comments on rarer outcomes, such as the rates of endophthalmitis. Secondly, due to the retrospective, chronological nature of the study, patients could not be randomized between groups. Lastly, it could be argued that, as the surgeon progressed to using the 25g instruments, his operative skill would also have progressed. However, since he had already been using the 25g system for 5 years for other conditions, this effect was unlikely to be significant. It is possible that a surgeon unfamiliar with the 25g system may have achieved different results. Moreover, it is also possible that with an alternative surgical system, different results between the groups with diverse gauge rates may have been found.
The fundamental finding of this investigation is that both 23g and 25g systems are highly effective for treating proliferative diabetic retinopathy. Advocates of the individual gauges have argued the advantages of both with the perceived advantages of 23g over 25g being its similar instrument handling to 20g and the advantages of 25g being its fluidic behaviour and smaller sclerostomy size. Our study shows that both can achieve good visual outcomes with a similar and low rate of postoperative complications. However, our study did indicate that operations conducted with the 25g system were less likely to induce transient hypotony or require a sclerostomy suture.
